Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women

This study is ongoing, but not recruiting participants.

Study NCT00705679 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: June 24, 2008 Last Updated: May 17, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2012 (Final data collection date for primary outcome measure)